Archives

by in
Entry Author Date Location
UCSF Chancellor Hawgood Kicks Off “Biotech’s Epicenter” Forum 12/17 10/28/14 San Francisco
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
One Week to Boston’s Life Science Disruptors—Check Out the Agenda 10/01/14 Boston
MyoKardia, Sanofi Ink $200M+ Deal for Targeted Heart Drugs 09/17/14 San Francisco
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
East Coast Biotech Roundup: Infinity, Merck, Voyager, Ebola, & More 09/05/14 Boston
Steven Paul, Former Lilly R&D Chief, Takes Head Seat at Voyager 09/03/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
Join Us For “Boston’s Life Science Disruptors” on Oct. 8 08/21/14 Boston
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
Sage, Despite Industry-Wide Pullback, Scores $90M in Upsized IPO 07/17/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
New Jounce CEO Aims to Place the Right Immuno-Oncology Bets 07/11/14 Boston
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
Katrine Bosley, Former Avila CEO, Takes Helm at Editas 06/24/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
BIO 2014: An Industry Surrounded by Insurmountable Opportunity 06/19/14 San Diego
Zafgen Hauls In $96M in Upsized IPO 06/18/14 Boston
Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs 06/18/14 Boston
One More Thought From Boston 2034: Tech + Biotech + Cleantech = ? 06/17/14 Boston
Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study 06/14/14 Boston
Lou Tartaglia Leaves Third Rock to Run High-Drama RNAi Startup 06/09/14 San Diego
Boston Consumer Tech and 4 Views of the Future: A 2034 Preview 06/04/14 Boston
As Expected, Nurix Taps Into $25M for New Drug Discovery 05/22/14 San Francisco
Page 1 of 12 next page »